PMID: 6407380Jul 1, 1983Paper

Acute hemodynamic effects of nitroglycerin in pulmonary hypertension

Annals of Internal Medicine
R G PearlJ P Ashton

Abstract

Therapy of pulmonary hypertension is limited by the low potency and adverse effects of current pulmonary vasodilators. The hemodynamic effects of nitroglycerin in human pulmonary hypertension are not known. We administered nitroglycerin to nine patients with chronic pulmonary hypertension. Nitroglycerin increased cardiac index 40% (p less than 0.01), increased stroke volume 40% (p less than 0.01), decreased pulmonary vascular resistance 40% (p less than 0.01), and decreased mean pulmonary artery pressure 15% (p less than 0.01). Pulmonary vascular resistance decreased more than 25% in eight of the nine patients. In four patients the effects of intravenous nitroglycerin were reproduced by topical nitroglycerin preparations; cardiac index increased 50%, stroke volume increased 48%, pulmonary vascular resistance decreased 43%, and mean pulmonary artery pressure decreased 19%. Five of six patients treated with long-acting nitrates had substantial improvement of their symptoms. We conclude that therapy with nitroglycerin can be effective in patients with severe pulmonary hypertension.

Citations

Oct 1, 1992·Pediatric Pulmonology·M A D'Angeli, B W Goetzman
Nov 1, 1995·Pediatric Cardiology·J FreemanR Pifarre
Sep 1, 1986·Canadian Anaesthetists' Society Journal·F A BurrowsD J Bohn
Aug 1, 1985·Journal of the American College of Cardiology·B HoitR Shabetai
Nov 1, 1995·Critical Care Medicine·I Matot, C F Neely
May 1, 1986·British Heart Journal·A RozkovecC M Oakley
May 1, 1985·Chest·J I Kennedy, J D Fulmer
Oct 1, 1984·Mayo Clinic Proceedings·M D McGoon, R E Vlietstra
May 1, 1990·Respiratory Medicine·A T Dinh XuanJ Wallwork
May 1, 1986·Chest·D G Kissner, R P Sorkin
Sep 24, 1992·The American Journal of Cardiology·J N Cohn
Nov 5, 1997·Clinics in Chest Medicine·H I Palevsky
Jun 22, 1984·The American Journal of Medicine·M PackerW H Lee
Nov 1, 1990·Respiratory Medicine·P J ChapmanS R Benatar
Oct 13, 1998·Anesthesia and Analgesia·R M Rodriguez, R G Pearl
Jan 1, 1987·British Journal of Clinical Pharmacology·R G AsmarM E Safar
Jan 1, 1985·British Journal of Clinical Pharmacology·J LevensonM E Safar
Aug 1, 1990·Anaesthesia and Intensive Care·N V Roberts, P J Keast
Nov 1, 1988·Progress in Cardiovascular Diseases·S Rich

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.